Skip to main content
. Author manuscript; available in PMC: 2022 Jul 22.
Published in final edited form as: Stem Cell Res. 2021 Apr 8;53:102342. doi: 10.1016/j.scr.2021.102342

Table 2.

Reagents details.

Antibodies and stains used for immunocytochemistry/flow-cytometry
Antibody Dilution Company Cat # and RRID

Pluripotency Markers Rabbit anti-OCT4 1:100 for immunostaining
1:60 for flow cytometry
Abcam Cat# ab181557, RRID: AB_2687916
Rabbit anti-SOX2 1: 100 Abcam Cat# ab92494, RRID: AB_10585428
Rabbit anti-NANOG 1: 100 Abcam Cat# ab21624, RRID: AB_446437
Differentiation Markers Rabbit anti-PAX6 1:100 BioLegend Cat# PRB-278P, RRID: AB_291612
Rabbit anti- BRACHYURY 1:100 Abcam Cat# ab209665, RRID: AB_2750925
Rabbit anti-FOXA2 1:100 Abcam Cat# ab108422, RRID: AB_11157157
RPE Markers Rabbit anti-ZO-1 1:100 Thermo Fisher Scientific Cat# 402200, RRID: AB_2533456
Mouse anti-MITF 1:100 Abcam Cat# ab3201, RRID: AB_303601
Mouse anti-RPE65 1:100 Novus Biologicals Cat# NB100-35 RRID:
AB_10002148
Western Blot analysis Rabbit anti-LRP2 1:300 Proteintech Cat# 9700-1-AP, RRID: N/A
Secondary antibodies Alexa Fluor 594 AffiniPure Donkey Anti-Rabbit IgG (H + L) 1:1000 Yeasen Cat# 34212ES60, RRID: N/A
AlexaFlour488 goat anti-rabbit IgG 1:1000 Thermo Fisher Scientific Cat# A-11008, RRID: AB_143165
AlexaFlour555 goat anti-mouse IgG 1:1000 Thermo Fisher Scientific Cat#A-21422, RRID: AB_2535844
Peroxidase-Conjugated Goat Anti-Rabbit IgG (H + L) 1:5000 Yeasen Cat# 33101ES60, RRID: N/A
Nuclear stain DAPI 1:1000 Abcam Cat# ab104139, RRID: N/A
Site-specific nuclease Nuclease information N/A N/A
Delivery method
Selection/enrichment strategy FACS FACS
Primers and Oligonucleotides used in this study
Target Forward/Reverse primer (5′–3′)
Targeted mutation analysis/sequencing LRP2, 2nd Exon of common sequence of three GCAGTATCTGGAGAATCTCTGTTTG/
transcripts GAGTTTCCACTAAATCTTGTCATTCAGC
gRNA oligonucleotide/crRNA sequence LRP2 GGCCAAGCCATTGGGCCATCC
Potential random integration-detecting PCRs PB1 ATACGATGTTCCAGATTACGCT/ GGTGTTTCGTCCTTTCCACAAG
PB2 CGTGTTTATCTCGTCAACTTGTTGG/CCAGTTTGGAACAAGAGTCCACTAT
PB3 CTCGAGGCGTTGACATTGAT/GTGGCACCGGTAGTTAGCC
Top off-target mutagenesis predicted site sequencing POT1 CTTTGCCCGGCCAAGAATTC/TCTGTCAGGCATCATGCTGGG
POT2 GTGGCATTCCGAATTCTGGC/GTGTTCACACCAGAGCCTGAG
POT3 CAGATGGTCAGAGCAGGCTC/TGATGAACCCTTGGGCCAAAG
POT4 CAGACGTGCCGATGAAGAGA/CCACAGGAACACTAGGCCAGT
POT5 AGTTTACTTGGTGTTCATTACCCA/TGGGCATTTGGAGGGACATCG